← Back to headlines
Pfizer Partners with Chai Discovery for AI Drug Development
Pfizer has announced a partnership with Chai Discovery to utilize its AI platform in drug development, joining other pharmaceutical giants like Eli Lilly in investing in AI drug discovery startups. This collaboration aims to accelerate the process of bringing new medicines to market.
4 Jun, 10:30 — 4 Jun, 15:17
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center1
Center (1)
forbes
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
forbes66d ago
Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup - Forbes
Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup Forbes
Read full article →seeking-alphaMixed66d ago
Pfizer in pact with Chai Discovery to use AI platform in drug development
Read full article →Coverage Timeline
First report: forbes · 4 Jun, 10:30|Full coverage: 2 · 5h|Window: 5h
Left-leaningCenterRight-leaning
